LIDOCAINE HYDROCHLORIDE

Product NDC: 60432-464
Requested package NDC: 60432-464-00
11-digit product format: 604320464
Labeler code: 60432
Product ID: 60432-464_9a96cd82-4720-4e42-af4a-a8e09cc86d7c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lidocaine hydrochloride
Dosage form: SOLUTION
Route: TOPICAL
Labeler: Morton Grove Pharmaceuticals, Inc.
Application: ANDA087872
Marketing category: ANDA
Marketing start: 1982-11-18
Marketing end: 0000-00-00
Substance: LIDOCAINE HYDROCHLORIDE
Active strength: 20 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	60432-464	60432-464-00	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A087872-001	LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1982-11-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A087872-001	AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A087872-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	1982-11-18	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A087872-001	AT	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A087872-001	AT	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A087872-001	AT	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A087872-001	AT	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A087872-001	AT	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A087872-001	AT	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A087872-001	AT	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A087872-001	AT	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A087872-001	AT	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A087872-001	AT	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A087872-001	AT	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A087872-001	AT	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A087872-001	AT	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A087872-001	AT	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A087872-001	AT	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A087872-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A087872-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A087872-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A087872-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A087872-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A087872-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A087872-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A087872-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A087872-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A087872-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A087872-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A087872-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A087872-001	AT	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A087872-001	AT	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A087872-001	AT	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A087872-001	AT	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A087872-001	AT	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A087872-001	AT	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A087872-001	AT	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A087872-001	AT	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A087872-001	AT	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A087872-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A087872-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A087872-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A087872-001	AT	1	`e64feba35796…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
60432-464-00	2025-12-10	C162847	48780-1	f386c649-e116-0266-e053-dadaa90a7c1a	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP 2% (VISCOUS)
60432-464-00	2023-01-30	C162847	48780-1	f386c649-e116-0266-e053-dadaa90a7c1a	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP 2% (VISCOUS)

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60432-464-00	ML - Milliliter	60432-464	8709575d-1920-426b-8ba0-eff44f451d4b	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Lidocaine Hydrochloride	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
Lidocaine	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
60432-464	LIDOCAINE HYDROCHLORIDE SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.]	12	Legacy NDC	20210408_b64806d2-da08-486c-8373-67efd6af9902.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine hydrochloride	LIDOCAINE HYDROCHLORIDE	Xttrium Laboratories, Inc.	40339593-1142-53ef-e063-6394a90afd4f	2025-10-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 087872 application number: ANDA087872

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V13007Z41A	LIDOCAINE HYDROCHLORIDE	6108-05-0	LIDOCAINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	a1d86942-1df3-4eb4-9a37-7fa2fbdd007b	2
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	cc85f481-599a-b281-e053-2a95a90a21b5	2
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	a1d86942-1df3-4eb4-9a37-7fa2fbdd007b	2
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	cc85f481-599a-b281-e053-2a95a90a21b5	2
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	a1d86942-1df3-4eb4-9a37-7fa2fbdd007b	2
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	cc85f481-599a-b281-e053-2a95a90a21b5	2
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	a1d86942-1df3-4eb4-9a37-7fa2fbdd007b	2
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	cc85f481-599a-b281-e053-2a95a90a21b5	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
60432-464-00	60432046400	100 mL in 1 BOTTLE, PLASTIC (60432-464-00)	100 ml	1982-11-18	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP 2% (VISCOUS)	Preferred Pharmaceuticals Inc.	2024-06-19	HUMAN PRESCRIPTION DRUG LABEL	4
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP 2% (VISCOUS)	REMEDYREPACK INC.	2024-01-15	HUMAN PRESCRIPTION DRUG LABEL	2
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP 2% (VISCOUS)	RPK Pharmaceuticals, Inc.	2023-09-11	HUMAN PRESCRIPTION DRUG LABEL	2
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP 2% (VISCOUS)	NuCare Pharmaceuticals,Inc.	2023-07-14	HUMAN PRESCRIPTION DRUG LABEL	2
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP 2% (VISCOUS)	Morton Grove Pharmaceuticals, Inc. \| Societa Italiana Medicinali Scandicci S.I.M.S. SrL - Italy	2021-04-07	HUMAN PRESCRIPTION DRUG LABEL	12